Harvard University
Cambridge, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Heart failure
FollowWhat is new in Heart failure research, which clinical trials are open, and who works on it. From public registries and PubMed, with the source and date of every fact.
Cure status
- AccelerometerPhase 3 · NCT06349941
- AcetazolamidePhase 3 · NCT07372040 · NCT07737964 · NCT06166654
- Allopurinol 200 mgPhase 3 · NCT05943821
- Alpha-Lipoic Acid (ALA)Phase 3 · NCT07725484
- AlprostadilPhase 3 · NCT00610051
- ApixabanPhase 3 · NCT07471139
- Aspirin tabletPhase 3 · NCT06082063
- AT-001Phase 3 · NCT04083339
- balcinrenone/dapagliflozin 15 mg/10 mg and matching placebo for dapagliflozin 10 mgPhase 3 · NCT06307652
- balcinrenone/dapagliflozin 40 mg/10 mg and matching placebo for dapagliflozin 10 mgPhase 3 · NCT06307652
- Baxdrostat and dapagliflozinPhase 3 · NCT06677060
- CABG surgeryPhase 3 · NCT07496372
- Chinese patent medicinePhase 3 · NCT06946095
- ColchicinePhase 3 · NCT06158698
- Colchicine 0.5 MGPhase 3 · NCT05873881
- Colchicine placeboPhase 3 · NCT05873881
- Colchicine TabletsPhase 3 · NCT06837623
- CyclophosphamidePhase 3 · NCT07654426 · NCT06220032
- DapagliflozinPhase 3 · NCT06304857
- dapagliflozin 10 mg and matching placebo for balcinrenone/dapagliflozinPhase 3 · NCT06307652
- Dapagliflozin 10 MG Oral Tablet [Farxiga]Phase 3 · NCT07025629
- Dapagliflozin 10 mg/day (oral)Phase 3 · NCT05374291
- Dapagliflozin 10mg TabPhase 3 · NCT06434025 · NCT07273838
- DexrazoxanePhase 3 · NCT07654426 · NCT06220032
- Direct oral anticoagulantPhase 3 · NCT05825573
- DoxorubicinPhase 3 · NCT07654426 · NCT06220032
- Early Discharge with Lasix® ONYU (furosemide injection, for subcutaneous use) using SQIN-InfusorPhase 3 · NCT07018297
- ElecoglipronPhase 3 · NCT07761117
- empagliflozinPhase 3 · NCT06507657 · NCT06683053 · NCT06024746 · NCT07372040 · NCT06570473 · NCT06935370 · NCT06424288
- Empagliflozin 10 MGPhase 3 · NCT05879276 · NCT05182658 · NCT05392764 · NCT05553938
- Empagliflozin 10 MG Oral Tablet [Jardiance]Phase 3 · NCT07038356
- EnavogliflozinPhase 3 · NCT06027307
- Ferric DerisomaltosePhase 3 · NCT07643818 · NCT06929806
- FinerenonePhase 3 · NCT07594145 · NCT07575672 · NCT06024746 · NCT07270367 · NCT06082063 · NCT06008197 · NCT06033950
- Finerenone (Kerendia, BAY94-8862)Phase 3 · NCT07192952 · NCT07188805
- FurosemidePhase 3 · NCT07737964
- Furosemide 20 MilligramsPhase 3 · NCT07008365
- Furosemide intravenous solutionPhase 3 · NCT07596329
- Glimepiride (oral)Phase 3 · NCT07288749
- Guideline-directed medical therapy (GDMT) for heart failurePhase 3 · NCT05824923
- HFrEF PolypillPhase 3 · NCT07569640
- HiCM-188 therapyPhase 3 · NCT07496372 · NCT06340048
- Human albuminPhase 3 · NCT06630923
- Hypertonic sodium chloride 10%Phase 3 · NCT07596329
- InclisiranPhase 3 · NCT06597006 · NCT06597019
- Iron CarboxymaltosePhase 3 · NCT06434025
- LenalidomidePhase 3 · NCT06220032
- Levosimendan 2.5 MG/ML Injectable SolutionPhase 3 · NCT04020263
- Maridebart cafraglutidePhase 3 · NCT07037459
- Matching Placebo (B)Phase 3 · NCT07234422
- MethylprednisolonePhase 3 · NCT05150704
- Metolazone 2.5 MGPhase 3 · NCT06166654
- Movn appPhase 3 · NCT06349941
- NNC0487-0111Phase 3 · NCT07567001
- NNC6019-0001Phase 3 · NCT07207811 · NCT06260709
- Omecamtiv Mecarbil (OM)Phase 3 · NCT06736574
- One tablet of placebo of dapagliflozin 10 mgPhase 3 · NCT07025629
- Optional interventionPhase 3 · NCT05943821
- PegfilgrastimPhase 3 · NCT06220032
- Pharmacological Rate ControlPhase 3 · NCT07238452
- PhosphocreatinePhase 3 · NCT06503016
- PrednisolonePhase 3 · NCT06220032
- Pulmonary arterial denervationPhase 3 · NCT05824923
- Pulmonary Vein IsolationPhase 3 · NCT07238452
- Qishen Yiqi Dripping Pills 2 bagsPhase 3 · NCT07687186
- Qishen Yiqi Dripping Pills placebo 2 bagsPhase 3 · NCT07687186
- RamiprilPhase 3 · NCT05508035
- RetatrutidePhase 3 · NCT06383390
- RituximabPhase 3 · NCT07654426 · NCT06220032
- Sacubitril / ValsartanPhase 3 · NCT05508035 · NCT07444398 · NCT06712030
- saline solutionPhase 3 · NCT05150704
- SemaglutidePhase 3 · NCT06082063
- SGLT2 inhibitorPhase 3 · NCT06142474 · NCT07172971
- Sodium Chloride 0.9%Phase 3 · NCT07596329
- Sodium zirconium cyclosilicatePhase 3 · NCT04789239 · NCT06578078
- SotagliflozinPhase 3 · NCT07594145 · NCT06082063 · NCT06217302 · NCT06435156
- SotaterceptPhase 3 · NCT07839585 · NCT06814145
- SpironolactonePhase 3 · NCT03593317 · NCT02901184
- Thiamine Mononitrate 300 mgPhase 3 · NCT05873881
- TirzepatidePhase 3 · NCT07738276
- TNX-103Phase 3 · NCT07436689 · NCT05983250 · NCT07288398
- To evaluate whether the efficacy of the study drug is noninferior to that of the positive control drugPhase 3 · NCT05553886
- TrametinibPhase 3 · NCT07817186
- vicadrostatPhase 3 · NCT06935370 · NCT06424288
- VincristinePhase 3 · NCT07654426 · NCT06220032
- Vitamin K antagonistPhase 3 · NCT05825573
- WarfarinPhase 3 · NCT07471139
- Wegovy ®Phase 3 · NCT07090343
- ZiltivekimabPhase 3 · NCT06200207
- Βeta-Blockers discontinued (with tapering)Phase 3 · NCT06518694
- Acetazolamide 250 milligrams.Phase 2/3 · NCT07469722
- BaroStimPhase 2/3 · NCT07399587
- Continue MRAsPhase 2/3 · NCT07489547
- D-shant Atrial ShuntPhase 2/3 · NCT07820410
- Dapagliflozin (10mg Tab)Phase 2/3 · NCT07469722
- Discontinuation of MRAsPhase 2/3 · NCT07489547
- Furosemide 40 Milligrams.Phase 2/3 · NCT07469722
- GDMTPhase 2/3 · NCT06128980
- Guideline-Directed Medical Therapy (GDMT) for heart failure with reduced ejection fractionPhase 2/3 · NCT07820410
- Hydrochlorothiazide (HCTZ) 25 milligrams.Phase 2/3 · NCT07469722
- istaroximePhase 2/3 · NCT07583446
- LevosimendanPhase 2/3 · NCT07262723
- Midodrine Oral TabletPhase 2/3 · NCT06405555
- Potassium Chloride Oral ProductPhase 2/3 · NCT07469722
- Remote ischemic preconditioningPhase 2/3 · NCT04982419
- Semaglutide Injectable ProductPhase 2/3 · NCT06423599
- Vericiguat suspensionPhase 2/3 · NCT05714085
- Vericiguat tabletPhase 2/3 · NCT07444398 · NCT05714085
- Weight lossPhase 2/3 · NCT07223242
- 18F-metaFluorobenzylguanidinePhase 2 · NCT06965621
- 5% Glucose Injection or 0.9% sodium chloride injectionPhase 2 · NCT07318103
- 68Ga-FAPI (gallium-68-labeled fibroblast activation protein inhibitor)Phase 2 · NCT07083011
- AB-1002Phase 2 · NCT05598333
- AC01Phase 2 · NCT07584967
- Activin ligand-trap biological therapyPhase 2 · NCT07202000
- air/oxygenPhase 2 · NCT04696523
- AnakinraPhase 2 · NCT05177822
- BivalirudinPhase 2 · NCT06080074
- BMS-986435Phase 2 · NCT06122779
- Bone marrow derived mononuclear cells and G-CSFPhase 2 · NCT03572660
- Cardiohelp device (VA-ECMO)Phase 2 · NCT06080074
- CD34+ stem cell therapyPhase 2 · NCT06154044
- CDR132LPhase 2 · NCT06979362 · NCT06979375
- CK-4021586 (150 mg, 300 mg, 450 mg, and 600 mg)Phase 2 · NCT06793371
- Combined Epoprostenol Sodium & MilrinonePhase 2 · NCT05450328
- Comparator: empa 10 plus spironolactonePhase 2 · NCT07857772
- CRD-4730Phase 2 · NCT07750873
- Cyclosporine APhase 2 · NCT05946772
- Dapagliflozin 10 mgPhase 2 · NCT07245069
- Dapagliflozin tabletPhase 2 · NCT06762964
- Dexrazoxane placeboPhase 2 · NCT07654426
- Digoxin 0.125 MGPhase 2 · NCT06240403
- EDG-15400 25 mgPhase 2 · NCT07795814
- EDG-15400 50 mgPhase 2 · NCT07795814
- empa plus vicaPhase 2 · NCT07857772
- Empagliflozin (EMPA)Phase 2 · NCT07692256
- Empagliflozin + Potassium ChloridePhase 2 · NCT05138575
- Empagliflozin + Potassium NitratePhase 2 · NCT05138575
- EpclusaPhase 2 · NCT03383419
- EplerenonePhase 2 · NCT07029503
- ErtugliflozinPhase 2 · NCT04438213
- Fasting XTR003/¹⁸F-FDG PET myocardial metabolic imagingPhase 2 · NCT07443696
- Finerenone Oral TabletPhase 2 · NCT06059664
- Glucose-loaded ¹⁸F-FDG PET Myocardial Metabolic ImagingPhase 2 · NCT07443696
- HeparinPhase 2 · NCT06080074
- High dose Jia Shen TabletPhase 2 · NCT06669169
- High Dose PF-07328948Phase 2 · NCT06991257
- HRS-1893 TabletPhase 2 · NCT07269717
- HRS-1893 Tablet PlaceboPhase 2 · NCT07269717
- HRS-7535 tabletPhase 2 · NCT06820099
- HRS-7535 tablet placeboPhase 2 · NCT06820099
- HRS-9057 injection setPhase 2 · NCT07318103
- HRS9531Phase 2 · NCT06391710
- Hyperpolarized 13C-pyruvatePhase 2 · NCT06645691
- IBI362Phase 2 · NCT06862908
- iSGLT2Phase 2 · NCT06929169
- Jia Shen Tablet PlaceboPhase 2 · NCT06669169
- JK07Phase 2 · NCT06369298
- KNO3Phase 2 · NCT05562167
- L-Arginine PowderPhase 2 · NCT07394270
- Liposomal DoxorubicinPhase 2 · NCT07654426
- Low anticoagulation dose of argatroban and enoxaparin during ECMOPhase 2 · NCT07499037
- Low Dose ColchicinePhase 2 · NCT06130059
- Low dose Jia Shen TabletPhase 2 · NCT06669169
- Low Dose PF-07328948Phase 2 · NCT06991257
- Lumacaftor 200 MGPhase 2 · NCT07695090
- Medium Dose PF-07328948Phase 2 · NCT06991257
- Mesenchymal stem cellPhase 2 · NCT07192211
- MethylprednisonePhase 2 · NCT07461961
- MetolazonePhase 2 · NCT04438213 · NCT07372040
- Normal salinePhase 2 · NCT05450328
- Percutaneous coronary interventionPhase 2 · NCT07560436
- PertuzumabPhase 2 · NCT04680442
- Polatuzumab VedotinPhase 2 · NCT07654426
- potassium binderPhase 2 · NCT07576257
- Potassium Chloride + Placebo for EmpagliflozinPhase 2 · NCT05138575
- Potassium NitratePhase 2 · NCT04913805
- Potassium Nitrate + Propionyl-L-Carnitine + Nicotinamide RibosidePhase 2 · NCT04913805
- PrednisonePhase 2 · NCT07654426
- Protocolized diuretic therapyPhase 2 · NCT04481919
- RanolazinePhase 2 · NCT06570473
- RilonaceptPhase 2 · NCT06660732
- Rubidium-82Phase 2 · NCT06965621
- SPC1001 LowPhase 2 · NCT07064525
- SPC5002Phase 2 · NCT07064525
- SPC5003Phase 2 · NCT07064525
- SPC5004Phase 2 · NCT07064525
- Spironolactone (drug)Phase 2 · NCT07304817
- Standard anticoagulation dose of argatroban and enoxaparin during ECMOPhase 2 · NCT07499037
- Standard medical treatmentPhase 2 · NCT07692256
- TamibarotenePhase 2 · NCT07855692
- TrastuzumabPhase 2 · NCT04680442
- Trastuzumab emtansinePhase 2 · NCT04680442
- TX000045- Dose APhase 2 · NCT06616974
- TX000045- Dose BPhase 2 · NCT06616974
- Uncultured, autologous, adipose-derived regenerative cells (UA-ADRCs)Phase 2 · NCT06705023
- Valsartan 40 mgPhase 2 · NCT06053580
- VericiguatPhase 2 · NCT06601465
- vicadrostat / empagliflozin combination 1Phase 2 · NCT07304817
- VslingPhase 2 · NCT06851949
- XenonPhase 2 · NCT04696523
- YMI024Phase 2 · NCT07830719
- AK1967 (Invobenitug also known as Procizumab)Phase 1/2 · NCT06832722
- Atibuclimab (IC14)Phase 1/2 · NCT06556810
- Blank Chitosan PatchPhase 1/2 · NCT07471698
- CABGPhase 1/2 · NCT07265349
- CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs)Phase 1/2 · NCT05925608
- CarvedilolPhase 1/2 · NCT05194111
- Combined prescription of the individual medicationsPhase 1/2 · NCT06143566
- Dapagliflozin 10 MG [Farxiga]Phase 1/2 · NCT05719714
- double placeboPhase 1/2 · NCT07687212
- EHM implantationPhase 1/2 · NCT04396899
- Empagliflozin 10 mg daily dosingPhase 1/2 · NCT05687058
- Empagliflozin 25 mg thrice-weekly post-hemodialysis dosingPhase 1/2 · NCT05687058
- FAP immunosuppressive CAR-DCPhase 1/2 · NCT07516288 · NCT06902896
- Fecal Microbiota Transplantation (FMT) CapsulesPhase 1/2 · NCT07628777
- GenisteinPhase 1/2 · NCT06634108
- HenggliflozinPhase 1/2 · NCT07687212
- Henggliflozin Combined with ProbioticsPhase 1/2 · NCT07687212
- HiCM-188 CellsPhase 1/2 · NCT07646210
- HiCM-188 Chitosan PatchPhase 1/2 · NCT07471698
- High dose CABG/LVAD+iPSC-CMsPhase 1/2 · NCT06866600
- HS-005Phase 1/2 · NCT07347197
- HS235Phase 1/2 · NCT07123779
- Injection PlaceboPhase 1/2 · NCT05279742
- low dose CABG+iPSC-CMsPhase 1/2 · NCT06866600
- MANPPhase 1/2 · NCT05279742
- Mesenchymal stem cells(HucMSCs)Phase 1/2 · NCT07265349
- Metformin HydrochloridePhase 1/2 · NCT07666698
- Oral PlaceboPhase 1/2 · NCT05279742
- PolyCore (Polydextrin, L-Carnitine, D-xylitol)Phase 1/2 · NCT03994874
- PolypillPhase 1/2 · NCT06143566
- Radiation TherapyPhase 1/2 · NCT07037524
- RelaxinPhase 1/2 · NCT07359872
- Sacubitril-ValsartanPhase 1/2 · NCT07856043 · NCT05194111
- Sacubitril/ValsartanPhase 1/2 · NCT05279742
- SRD-001Phase 1/2 · NCT04703842
- ValsartanPhase 1/2 · NCT05194111
- [11C]PS13: [carbon-11]PS13; COX-1 PET radioligandPhase 1 · NCT07856043
- [14C]HRS-9057Phase 1 · NCT07681479
- 18F-FDGPhase 1 · NCT07838649
- 68Ga-GalmydarPhase 1 · NCT07838649
- AAV1/SERCA2aPhase 1 · NCT06061549
- Acetylcholine, Sodium Nitroprusside, Angiotensin-II, Norepinephrine, PhentolaminePhase 1 · NCT02966665
- AD-118, AD-1181Phase 1 · NCT07476157 · NCT07717749
- AmiloridePhase 1 · NCT05753059
- Ammonium ChloridePhase 1 · NCT06209359
- AtorvastatinPhase 1 · NCT06312748
- BendroflumethiazidePhase 1 · NCT05753059
- BH4Phase 1 · NCT06312748
- BH4, L-NMMA, Vitamin C, Vitamin E, α-Lipoic Acid and L-AscorbatePhase 1 · NCT02966665
- BQ-123Phase 1 · NCT02966665
- BQ-123, MitoQ, BH4Phase 1 · NCT02966665
- Bumetanide InjectionPhase 1 · NCT05323487
- CDR132L (i.v.)Phase 1 · NCT07656454
- CDR132L (s.c.)Phase 1 · NCT07656454
- Extracellular vesicle-enriched secretome of cardiovascular progenitor cells differentiated from induced pluripotent stem cellsPhase 1 · NCT05774509
- Fexofenadine, RanitidinePhase 1 · NCT02966665
- HB1011 (Allogeneic Myocardium-derived Mesenchymal Stem Cells)Phase 1 · NCT07861035
- HJB647 high dosePhase 1 · NCT07465653
- HJB647 low dosePhase 1 · NCT07465653
- HRS-5765 TabletPhase 1 · NCT07551167
- HRS-5765 Tablet PlaceboPhase 1 · NCT07551167
- HRS-7156Phase 1 · NCT07601087
- HRS-7156 placeboPhase 1 · NCT07601087
- iPSC-CLPhase 1 · NCT05647213
- L-CitrullinePhase 1 · NCT06312748
- LY3971297Phase 1 · NCT07547540
- MTP-101-C encapsulated MicrobiotaPhase 1 · NCT07490054
- NeomycinPhase 1 · NCT07490054
- NNC0537-1482Phase 1 · NCT07218627
- PET/MRIPhase 1 · NCT07838649
- Protek Solo Transseptal CannulaPhase 1 · NCT06770023
- ResmetiromPhase 1 · NCT07830758
- RP-A701 is a recombinant viral vector composed of an AAV serotype rh.74 (AAVrh.74) capsid encapsulating the transgene, BCL2-associated Athanogene 3 (BAG3)Phase 1 · NCT07137338
- SGLT-2 inhibitorPhase 1 · NCT07172971
- SHR-4658 Injection.Phase 1 · NCT07230145
- SHR-4658 Placebo InjectionPhase 1 · NCT07230145
- STM01Phase 1 · NCT06560762
- TN-401Phase 1 · NCT06228924
- VancomycinPhase 1 · NCT07490054
- VB-C01 cellularised patchPhase 1 · NCT06956807
- VS-041Phase 1 · NCT07219511
- YAP101 (AAV9-Sav-shRNA)Phase 1 · NCT06831825
- 1:1 Randomization to receive milrinoneEarly phase 1 · NCT05700617
- Acipimox 250 Mg Oral CapsuleEarly phase 1 · NCT06229678
- AdenosineEarly phase 1 · NCT04600115
- Diffusion Tensor MRI (DTI)Early phase 1 · NCT02973633
- Empagliflozin 25 MGEarly phase 1 · NCT05057806
- Empagliflozin 25 MG Oral TabletEarly phase 1 · NCT06229678
- Exosome PreparationEarly phase 1 · NCT07883317
- Ferumoxytol infusionEarly phase 1 · NCT07634640
- Gadolinium DOTA MeglumineEarly phase 1 · NCT02973633
- Ketone Monoester (KE)Early phase 1 · NCT06108076
- LevocarnitineEarly phase 1 · NCT07201714
- MRIEarly phase 1 · NCT04600115
- Nicotinamide ribosideEarly phase 1 · NCT04528004
- O-15 labeled radioactive waterEarly phase 1 · NCT04600115
- PET ImagingEarly phase 1 · NCT04600115
- RegadenosonEarly phase 1 · NCT04600115
Closest to patients
- Safety and Efficacy of AT-001 in Patients With Diabetic CardiomyopathySafety and Efficacy of AT-001 in Patients With Diabetic CardiomyopathyNew Generation of Medical Research · Hialeah, United States + 78 more hospitalsPhase 3Primary completion 2023
- Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient DepartmentEvaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient DepartmentMultidisciplinary Center for Specialized Education and Research Ltd. · Joinville, BrazilPhase 3Primary completion 2024
- Anticoagulation Therapy in Non-device-related Intra-cardiac ThrombusAnticoagulation Therapy in Non-device-related Intra-cardiac ThrombusCHU Limoges · Limoges, France + 34 more hospitalsPhase 3Primary completion 2025
Let us optimize your content
Apply for experimental treatment or a research study
The trial team decides who can take part; your doctor can help you ask.
Distance is calculated in your browser. Your city is not sent to us.
Loading trial sites…
Latest news
Results, new trials and publications, newest first. Every item links to its source.
Results and new studies, newest first, in plain words.
Plain-language summary pending. Original title shown.
Publication
Distinct phenotypes associated with the same homozygous ENPP1 c.26dup variant.
Distinct phenotypes associated with the same homozygous ENPP1 c.26dup variant.
Journal of pediatric endocrinology & metabolism : JPEM
PubMed · PMID 42984211Publication
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to the presence of echocardiographic features of diastolic dysfunction in the EMPEROR-Preserved trial.
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to the presence of echocardiographic features of diastolic dysfunction in the EMPEROR-Preserved trial.
European journal of heart failure
PubMed · PMID 42986123Review
Global Trends in Guideline-Directed Medical Therapy for Patients With Heart Failure: A Bibliometric and Thematic Analysis of Articles Indexed in Scopus (2013-2025).
Global Trends in Guideline-Directed Medical Therapy for Patients With Heart Failure: A Bibliometric and Thematic Analysis of Articles Indexed in Scopus (2013-2025).
Journal of primary care & community health
PubMed · PMID 42987129Systematic review
Efficacy of sodium-glucose cotransporter-2 inhibitors on functional mitral regurgitation associated with heart failure: a systematic review and meta-analysis of randomized controlled trials.
Efficacy of sodium-glucose cotransporter-2 inhibitors on functional mitral regurgitation associated with heart failure: a systematic review and meta-analysis of randomized controlled trials.
Frontiers in cardiovascular medicine
PubMed · PMID 42984665
Organisations that can help
Helplines, patient groups and support services for you and your family.
International & European
European Heart Network
Alliance of national heart foundations and associations (some representing patients); EU-level prevention policy and patient interest advocacy. Mixed, not purely patient-led.
Visit site: European Heart NetworkEuropean Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
Visit site: European Patients' Forum (EPF)Global Heart Hub
Global umbrella of heart patient organisations; runs a Heart Failure Patient Network, awareness campaigns, advocacy and patient resources.
Visit site: Global Heart HubInternational Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Visit site: International Alliance of Patients' OrganizationsWorld Heart Federation
Global cardiovascular federation (mixed: heart foundations, medical societies and advocacy groups, not purely patient-led); campaigns, policy and World Heart Day.
Visit site: World Heart Federation
Frontlight is not affiliated with these organisations; we list them because they help.
Checked automatically every 90 days.
Find fellow researchers
Groups with active Heart failure work.
Mayo Clinic
Rochester, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Brigham and Women's Hospital
Boston, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Inserm
Paris, France
Team details appear once the team leader joins.
Is this your team? Claim it
Cleveland Clinic
Cleveland, United States
Team details appear once the team leader joins.
Is this your team? Claim it
German Centre for Cardiovascular Research
Berlin, Germany
Team details appear once the team leader joins.
Is this your team? Claim it
Johns Hopkins University
Baltimore, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
Team details appear once the team leader joins.
Is this your team? Claim it
Massachusetts General Hospital
Boston, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Stanford University
Stanford, United States
Team details appear once the team leader joins.
Is this your team? Claim it
University of Glasgow
Glasgow, United Kingdom
Team details appear once the team leader joins.
Is this your team? Claim it
The University of Texas Southwestern Medical Center
Dallas, United States
Team details appear once the team leader joins.
Is this your team? Claim it